(Q27020973)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Fabrice André

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sherene Loi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Charles Swanton

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

S Delaloge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

H A Azim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

F Zagouri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Filipits

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

M Namer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

P Neven

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

W F Symmans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A Thompson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

1 reference

20 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

24

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

647-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

Molecular portraits of human breast tumours

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

The influence of a gene expression profile on breast cancer decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Interpretation of microarray data in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Repeatability of published microarray gene expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Use of archived specimens in evaluation of prognostic and predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS645

Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23337633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23337633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/ANNONC/MDS645

2 references

Consolidated OpenCitations Corpus – April 2017

3521687

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3521687

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

23337633

2 references

Consolidated OpenCitations Corpus – April 2017

3521687

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337633%20AND%20SRC:MED&resulttype=core&format=json